Skip to main content
Clinical Trials/NCT01837394
NCT01837394
Completed
Phase 4

Ultrasound-guided Block of the Saphenous Nerve and Obturator Nerve, Posterior Branch, for Postoperative Pain Management After Ambulatory Knee Arthroscopy

Jens Borglum Neimann1 site in 1 country60 target enrollmentAugust 2012

Overview

Phase
Phase 4
Intervention
Block of the SN and ONP
Conditions
Postoperative Pain
Sponsor
Jens Borglum Neimann
Enrollment
60
Locations
1
Primary Endpoint
Pain on knee flexion
Status
Completed
Last Updated
12 years ago

Overview

Brief Summary

In this study, we wish to investigate the effect of ultrasound (US) -guided block of the saphenous nerve (SN) and the posterior branch of the obturator nerve (ONP) on postoperative pain and the use of opioids (morphine-like pain medicine) in the first 24 hours following ambulatory knee arthroscopy.

We wish to investigate the analgesic effect of these two blocks compared to placebo (injection of local anesthetic with known pain blocking properties compared with injection of a saline solution), when used as a supplement to conventional oral analgesics.

We hypothesize that patients receiving the active treatment may experience less pain during the first 24 hours after their operation than patients receiving the placebo treatment, and possibly require less opioid analgesics, experience less opioid related side effects and have a higher function level in this period than patients receiving the placebo treatment.

Registry
clinicaltrials.gov
Start Date
August 2012
End Date
September 2013
Last Updated
12 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
Jens Borglum Neimann
Responsible Party
Sponsor Investigator
Principal Investigator

Jens Borglum Neimann

MD, PhD, MBA

Bispebjerg Hospital

Eligibility Criteria

Inclusion Criteria

  • Planned ambulatory knee arthroscopy, except cruciate ligament surgery
  • American Society of Anesthesiologists (ASA) class 1-3

Exclusion Criteria

  • Cannot cooperate
  • Do not speak or understand Danish
  • Daily use of opioid analgesics
  • Allergy towards any of the drugs used in the investigation
  • Medicine abuse (at the investigators discretion)
  • Alcohol abuse, as defined by the National Board of Health
  • General anesthesia contraindicated, or the patient wants spinal anesthesia
  • Visualization of necessary structures by ultrasound not possible, or block not possible for other technical reasons

Arms & Interventions

Block arm

Ultrasound guided block of the SN and ONP with 7.5 ml of Ropivacaine 7.5 mg/ml injected at each site, respectively, immediately prior to induction of general anesthesia. Standard postoperative analgesia with paracetamol 1 g every 6 hours and Morphine 5 mg as needed. Ondansetron or Metoclopramide as needed for nausea.

Intervention: Block of the SN and ONP

Block arm

Ultrasound guided block of the SN and ONP with 7.5 ml of Ropivacaine 7.5 mg/ml injected at each site, respectively, immediately prior to induction of general anesthesia. Standard postoperative analgesia with paracetamol 1 g every 6 hours and Morphine 5 mg as needed. Ondansetron or Metoclopramide as needed for nausea.

Intervention: Paracetamol

Block arm

Ultrasound guided block of the SN and ONP with 7.5 ml of Ropivacaine 7.5 mg/ml injected at each site, respectively, immediately prior to induction of general anesthesia. Standard postoperative analgesia with paracetamol 1 g every 6 hours and Morphine 5 mg as needed. Ondansetron or Metoclopramide as needed for nausea.

Intervention: Morphine

Block arm

Ultrasound guided block of the SN and ONP with 7.5 ml of Ropivacaine 7.5 mg/ml injected at each site, respectively, immediately prior to induction of general anesthesia. Standard postoperative analgesia with paracetamol 1 g every 6 hours and Morphine 5 mg as needed. Ondansetron or Metoclopramide as needed for nausea.

Intervention: Ondansetron

Block arm

Ultrasound guided block of the SN and ONP with 7.5 ml of Ropivacaine 7.5 mg/ml injected at each site, respectively, immediately prior to induction of general anesthesia. Standard postoperative analgesia with paracetamol 1 g every 6 hours and Morphine 5 mg as needed. Ondansetron or Metoclopramide as needed for nausea.

Intervention: Metoclopramide

Placebo arm

Ultrasound guided placebo block of the SN and ONP with 7.5 ml of isotonic saline solution injected at each site, respectively, immediately prior to induction of general anesthesia. Standard postoperative analgesia with paracetamol 1 g every 6 hours and Morphine 5 mg as needed. Ondansetron or Metoclopramide as needed for nausea.

Intervention: Placebo block

Placebo arm

Ultrasound guided placebo block of the SN and ONP with 7.5 ml of isotonic saline solution injected at each site, respectively, immediately prior to induction of general anesthesia. Standard postoperative analgesia with paracetamol 1 g every 6 hours and Morphine 5 mg as needed. Ondansetron or Metoclopramide as needed for nausea.

Intervention: Paracetamol

Placebo arm

Ultrasound guided placebo block of the SN and ONP with 7.5 ml of isotonic saline solution injected at each site, respectively, immediately prior to induction of general anesthesia. Standard postoperative analgesia with paracetamol 1 g every 6 hours and Morphine 5 mg as needed. Ondansetron or Metoclopramide as needed for nausea.

Intervention: Morphine

Placebo arm

Ultrasound guided placebo block of the SN and ONP with 7.5 ml of isotonic saline solution injected at each site, respectively, immediately prior to induction of general anesthesia. Standard postoperative analgesia with paracetamol 1 g every 6 hours and Morphine 5 mg as needed. Ondansetron or Metoclopramide as needed for nausea.

Intervention: Ondansetron

Placebo arm

Ultrasound guided placebo block of the SN and ONP with 7.5 ml of isotonic saline solution injected at each site, respectively, immediately prior to induction of general anesthesia. Standard postoperative analgesia with paracetamol 1 g every 6 hours and Morphine 5 mg as needed. Ondansetron or Metoclopramide as needed for nausea.

Intervention: Metoclopramide

Outcomes

Primary Outcomes

Pain on knee flexion

Time Frame: 24 hours postoperatively

VRS (Verbal Rating Scale) score 0-10 on active flexion of the knee to 45 degrees, measured at 0, ½, 1, 2, 3, 4, 6, 8, 12 and 24 hours postoperatively and analyzed by area under curve (AUC) analysis.

Secondary Outcomes

  • Use of antiemetics(24 hours)
  • PACU length of stay(24 hours)
  • Nausea(24 hours postoperatively)
  • Function level: Short form (SF) -8(24 hours)
  • Pain at rest(24 hours postoperatively)
  • Time to opioid intake(24 hours postoperatively)
  • Total opioid intake(24 hours)
  • Vomiting(24 hours)
  • Function level: Barthel Index/100(24 hours)

Study Sites (1)

Loading locations...

Similar Trials